USPTO trademark

GILGAMESH PHARMA

Under examinationUSPTOWord markClass 5

"GILGAMESH PHARMA" is a word mark owned by Gilgamesh Pharmaceuticals, Inc., filed at the USPTO on July 9, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Gilgamesh Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
GILGAMESH PHARMA trademark as filed
As filed with the USPTO
Status
Under examination
Since October 13, 2026
Filed
July 9, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99932547
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns GILGAMESH PHARMA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Gilgamesh Pharmaceuticals, Inc.

New York, United States

3 trademarks in the portfolioView company

Representative

Keith A. Weltsch

Scully, Scott, Murphy & Presser, P.C.

Goods and services

What the mark covers

The products and services GILGAMESH PHARMA is filed for, grouped by Nice class.

  • Pharmaceuticals, namely, pharmaceutical and drug preparations and substances for use in treating cancer and for use in the field of neuroscience for use in the treatment and therapy of psychiatric disorders, depression disorders, substance use, substance abuse, anxiety disorders, cognitive disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorders, eating disorders, pain, dementia, sleep disorders, attention deficit disorder, autism, schizophrenia, and longevity; Diagnostic biomarker reagents for pharmaceutical and medical purposes; predictive biomarker reagents for medical use, namely, for pharmaceuticals and drugs for use in treating cancer and in the field of neuroscience for use in the treatment and therapy of psychiatric disorders, depression disorders, substance use, substance abuse, anxiety disorders, cognitive disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorders, eating disorders, pain, dementia, sleep disorders, attention deficit disorder, autism, schizophrenia, and longevity

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of non-final action e-mailed
  2. Non-final action e-mailed
  3. Non-final action written
  4. Assigned to examiner
  5. Application filing receipt mailed
  6. New application office supplied data entered
  7. New application entered
FAQ

About GILGAMESH PHARMA

Who owns the trademark "GILGAMESH PHARMA"?

The USPTO trademark "GILGAMESH PHARMA" (application 99932547) is owned by Gilgamesh Pharmaceuticals, Inc.

What is the status of "GILGAMESH PHARMA"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull GILGAMESH PHARMA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019f4c2e-b3b2-703a-8c0c-d6629dff2458
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019f4c2e-b3b2-703a-8c0c-d6629dff2458",
  "object": "trademark",
  "mark_text": "GILGAMESH PHARMA",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99932547",
  "filing_date": "2026-07-09",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "GILGAMESH PHARMACEUTICALS, INC.",
      "entity_id": "ent_019eb718-2e15-77bc-9e11-eeb3926a089e"
    }
  ]
}